All In MedTech

Device Trial Radar · NCT07941011

Hyaluronic Acid Barrier in Parotidectomy

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jan 1, 2027

Primary completion

Jan 31, 2029

Study completion Jan 31, 2029

Sponsor

Lead sponsor
Milton S. Hershey Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Axogen Corporation
First posted
Nov 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of AxoGuard HA+ (hyaluronic acid nerve protector) in preventing Frey syndrome following parotidectomy. A parotidectomy is a surgical procedure to remove all or part of the parotid gland, the largest salivary gland located near the ear and jaw. The specific aims are to determine whether placement of AxoGuard HA+ during parotidectomy can significantly reduce both clinical and subclinical incidence of Frey syndrome compared to standard surgical technique alone.

Conditions

  • Parotidectomy, Patient-reported Outcomes
  • Parotid Cancer
  • Parotid Gland Tumor
  • Parotidectomy
  • Frey's Syndrome

Interventions

  • Axoguard HA+ Nerve ProtectorDevice

    AxoGuard HA+ nerve protector is an FDA-approved device available for clinical use, but its specific efficacy in preventing Frey syndrome following parotidectomy has not been systematically evaluated in controlled trials.

  • ParotidectomyProcedure

    A parotidectomy is a surgical procedure to remove all or part of the parotid gland, the largest salivary gland located near the ear and jaw.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of subjects with positive Starch-Iodine testTime frame: 3 months post-op

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.